Drug Database
Back to search

Belgium· BE-AMP-SAM057197-00

Visine 0.5 mg/ml

A tetryzoline product containing tetryzoline hydrochloride, registered in Belgium by Kenvue Belgium. The same ATC class is registered in 6 of our 19 countries.

ATC S01GA02

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedVisine 0.5 mg/mlATCS01GA02REGISTER NO.BE-AMP-SAM057197-00PACKS LISTED1CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about tetryzoline hydrochlorideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Tetryzoline is registered in 6 of 19 countries.

Countries holding a registration under ATC S01GA02 (tetryzoline), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 5 of them publish a price we can compare per daily dose
Search tetryzoline products by name

Tetryzoline · ATC S01GA02

6 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Finlandprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Tetryzoline Hydrochloride
Manufacturer
Kenvue Belgium
Country
Belgium (BE)
ATC code
S01GA02
ATC class
Tetryzoline
Defined daily dose
62.5 mcg, AT
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 1

  • be_apb
    0817551

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

53 interactions on record for tetryzoline.

Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check tetryzoline against other medicinesHow interaction checks work

Tetryzoline · interactions on record

53 records

  • 7 severe
  • 46 moderate

Most severe, free to view

  • MethylergometrineG02AB01severe
  • ErgometrineG02AB03severe
  • DihydroergotamineN02CA01severe
  • ErgotamineN02CA02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Tetryzoline in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tetryzoline products

Authorised across Europe · EMA

The same active substance is authorised in 19 EEA countries. Names it is sold under:

  • Bulgaria · Визин Ново, Сенсилукс
  • Cyprus · Vispring Advance
  • Czechia · Visine Rapid
  • Germany · Berberil N, Berberil N Edo
  • Estonia · Visine
  • Spain · Optispring, Vispring
  • Finland · Oftan Starine
  • Greece · Vispring Advance
  • Croatia · Viset, Visiklear
  • Hungary · Visine Rapid, Vizored
  • Italy · Octilia, Stilla Decongestionante
  • Lithuania · Visine
  • Luxembourg · Berberil N, Berberil N Edo
  • Latvia · Visine
  • Poland · Starazolin, Starazolin Free
  • Portugal · Visine
  • Romania · Visine Novo
  • Slovenia · Neored Kapljice Za Oko, Visiklear
  • Slovakia · Sensilux, Visine Rapid

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/905d8a5f-5ac3-4193-b3e7-0a1e459077c8
GET /v1/drugs/905d8a5f-5ac3-4193-b3e7-0a1e459077c8?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Eye drops, solution",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Visine 0.5 mg/ml",
  "name_fr": "Visine 0.5 mg/ml",
  "name_nl": "Visine 0.5 mg/ml",
  "amp_code": "SAM057197-00",
  "strengths": [
    "0.5000",
    "0.5000",
    "0.5000",
    "0.2000",
    "0.5000",
    "12.3000",
    "2.2000",
    "1.0000"
  ],
  "pack_count": 1,
  "substances": [
    "Tetryzoline Hydrochloride",
    "Benzalkonium Chloride",
    "Borax",
    "Boric Acid",
    "Sodium Chloride",
    "Sodium Edetate"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Tetryzoline",
  "authorisation_numbers": [
    "BE057197"
  ]
}
API referenceMCP serverPlans

See everything about tetryzoline.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console